These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 36339295)
1. A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease. Thijssen E; Makai-Bölöni S; van Brummelen E; den Heijer J; Yavuz Y; Doll RJ; Groeneveld GJ Mov Disord Clin Pract; 2022 Nov; 9(8):1074-1084. PubMed ID: 36339295 [TBL] [Abstract][Full Text] [Related]
2. Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks. ZhuParris A; Thijssen E; Elzinga WO; Makai-Bölöni S; Kraaij W; Groeneveld GJ; Doll RJ Mov Disord; 2023 Oct; 38(10):1795-1805. PubMed ID: 37401265 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration. Papapetropoulos S; Liu W; Duvvuri S; Thayer K; Gray DL Neurodegener Dis; 2018; 18(5-6):262-269. PubMed ID: 30453303 [TBL] [Abstract][Full Text] [Related]
4. Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's disease. Hauser RA; Ellenbogen A; Khanna S; Gupta S; Modi NB Neuropsychiatr Dis Treat; 2018; 14():839-845. PubMed ID: 29606877 [TBL] [Abstract][Full Text] [Related]
5. Developing and assessing a new web-based tapping test for measuring distal movement in Parkinson's disease: a Distal Finger Tapping test. Akram N; Li H; Ben-Joseph A; Budu C; Gallagher DA; Bestwick JP; Schrag A; Noyce AJ; Simonet C Sci Rep; 2022 Jan; 12(1):386. PubMed ID: 35013372 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacodynamics of IPX066: an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease. Mao Z; Hsu A; Gupta S; Modi NB J Clin Pharmacol; 2013 May; 53(5):523-31. PubMed ID: 23426902 [TBL] [Abstract][Full Text] [Related]
7. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study. Juhász A; Aschermann Z; Ács P; Janszky J; Kovács M; Makkos A; Harmat M; Tényi D; Karádi K; Komoly S; Takáts A; Tóth A; Nagy H; Klivényi P; Dibó G; Dézsi L; Zádori D; Annus Á; Vécsei L; Varannai L; Kovács N Parkinsonism Relat Disord; 2017 Apr; 37():79-86. PubMed ID: 28185758 [TBL] [Abstract][Full Text] [Related]
8. Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis. Kano O; Tsuda H; Hayashi A; Arai M Parkinsons Dis; 2022; 2022():4216452. PubMed ID: 36081594 [TBL] [Abstract][Full Text] [Related]
9. The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia? Williams S; Zhao Z; Hafeez A; Wong DC; Relton SD; Fang H; Alty JE J Neurol Sci; 2020 Sep; 416():117003. PubMed ID: 32645513 [TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease severity clustering based on tapping activity on mobile device. Surangsrirat D; Sri-Iesaranusorn P; Chaiyaroj A; Vateekul P; Bhidayasiri R Sci Rep; 2022 Feb; 12(1):3142. PubMed ID: 35210451 [TBL] [Abstract][Full Text] [Related]
11. Quantifying Parkinson's disease motor severity under uncertainty using MDS-UPDRS videos. Lu M; Zhao Q; Poston KL; Sullivan EV; Pfefferbaum A; Shahid M; Katz M; Montaser-Kouhsari L; Schulman K; Milstein A; Niebles JC; Henderson VW; Fei-Fei L; Pohl KM; Adeli E Med Image Anal; 2021 Oct; 73():102179. PubMed ID: 34340101 [TBL] [Abstract][Full Text] [Related]
12. A low-cost vision system based on the analysis of motor features for recognition and severity rating of Parkinson's Disease. Buongiorno D; Bortone I; Cascarano GD; Trotta GF; Brunetti A; Bevilacqua V BMC Med Inform Decis Mak; 2019 Dec; 19(Suppl 9):243. PubMed ID: 31830986 [TBL] [Abstract][Full Text] [Related]
13. Comparing kinematic changes between a finger-tapping task and unconstrained finger flexion-extension task in patients with Parkinson's disease. Teo WP; Rodrigues JP; Mastaglia FL; Thickbroom GW Exp Brain Res; 2013 Jun; 227(3):323-31. PubMed ID: 23686150 [TBL] [Abstract][Full Text] [Related]
14. Parkinsonian Hand or Clinician's Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts. Williams S; Wong D; Alty JE; Relton SD J Parkinsons Dis; 2023; 13(4):525-536. PubMed ID: 37092233 [TBL] [Abstract][Full Text] [Related]
15. Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge. Merello M; Gerschcovich ER; Ballesteros D; Cerquetti D Parkinsonism Relat Disord; 2011 Nov; 17(9):705-7. PubMed ID: 21784692 [TBL] [Abstract][Full Text] [Related]
16. Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules. Modi NB; Mittur A; Rubens R; Khanna S; Gupta S Clin Neuropharmacol; 2019; 42(1):4-8. PubMed ID: 30520758 [TBL] [Abstract][Full Text] [Related]
17. Using AI to measure Parkinson's disease severity at home. Islam MS; Rahman W; Abdelkader A; Lee S; Yang PT; Purks JL; Adams JL; Schneider RB; Dorsey ER; Hoque E NPJ Digit Med; 2023 Aug; 6(1):156. PubMed ID: 37608206 [TBL] [Abstract][Full Text] [Related]